Judge Refuses to Block Mailing Abortion Pills, Orders FDA Review
A federal judge in Louisiana has declined to immediately block the mailing of mifepristone, the abortion pill, across the United States. U.S. District Judge David Joseph ruled against Louisiana Attorney General Liz Murrill’s request to pause FDA regulations that allow telehealth prescriptions and mail-order distribution. However, the judge warned that this reprieve is temporary and mandated the FDA to complete its ongoing review of the drug’s safety and regulations within six months. He indicated that if the agency fails to act within a reasonable timeframe, the court’s stance could shift, noting that plaintiffs are likely to succeed on the merits eventually. This ruling represents a setback for Louisiana’s efforts to restrict access to abortion pills in states with strict bans. The case highlights the ongoing legal battles following the overturning of Roe v. Wade, with conservative states challenging federal access rules while liberal states protect telehealth providers. Arguments regarding potential coercion and intimate partner abuse were central to the plaintiffs' case, though advocates argue telehealth remains vital for survivors.
Wire timeline
Judge Refuses to Block Mailing Abortion Pills, Orders FDA Review
A federal judge in Louisiana has declined to immediately block the mailing of mifepristone, the abortion pill, across the United States. U.S. District Judge David Joseph ruled against Louisiana Attorney General Liz Murrill’s request to pause FDA regulations that allow telehealth prescriptions and mail-order distribution. However, the judge warned that this reprieve is temporary and mandated the FDA to complete its ongoing review of the drug’s safety and regulations within six months. He indicated that if the agency fails to act within a reasonable timeframe, the court’s stance could shift, noting that plaintiffs are likely to succeed on the merits eventually. This ruling represents a setback for Louisiana’s efforts to restrict access to abortion pills in states with strict bans. The case highlights the ongoing legal battles following the overturning of Roe v. Wade, with conservative states challenging federal access rules while liberal states protect telehealth providers. Arguments regarding potential coercion and intimate partner abuse were central to the plaintiffs' case, though advocates argue telehealth remains vital for survivors.
AP News